RA

Reena Arya

Active Director Director DIN 08758953
DIN 08758953 First appointment Jun 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2020
Shareholding value Locked Premium profile

About Reena Arya

Reena Arya has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Sunovion Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08758953
Primary Designation Director
First Appointment 10 Jun 2020
Oldest Company Age 6 yrs

Current companies

Company Designation Appointment Founded Status
Director 10 Jun 2020 2020 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sunovion Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Reena Arya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Arya

Reena Arya has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Sunovion Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

Reena Arya is associated with 1 company as Director.

Reena Arya has expertise in General Business.

Reena Arya has 6 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available